Allogene Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $415.9M
Liabilities Breakdown FY2025
Total Liabilities: $123.4M
Asset Breakdown
Total Assets: $415.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $51.7M | 12.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $72.8M | 17.5% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $291.4M | 70.1% |
Liabilities Breakdown
Total Liabilities: $123.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.3M | 3.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $119.1M | 96.5% |